BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3825999)

  • 1. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.
    Bartl R; Frisch B; Fateh-Moghadam A; Kettner G; Jaeger K; Sommerfeld W
    Am J Clin Pathol; 1987 Mar; 87(3):342-55. PubMed ID: 3825999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
    Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
    Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic classification and staging of chronic lymphocytic leukemia. A retrospective and prospective study of 503 cases.
    Frisch B; Bartl R
    Acta Haematol; 1988; 79(3):140-52. PubMed ID: 3128037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
    Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
    Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.
    Bartl R; Frisch B; Diem H; Mündel M; Fateh-Moghadam A
    Eur J Haematol Suppl; 1989; 51():88-98. PubMed ID: 2697597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
    Pasqualetti P; Colantonio D; Collacciani A; Casale R; Natali G
    Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histomorphology of multiple myeloma on bone marrow biopsy.
    Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
    Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between karyotype and cytologic findings in multiple myeloma.
    Weh HJ; Bartl R; Seeger D; Selbach J; Kuse R; Hossfeld DK
    Leukemia; 1995 Dec; 9(12):2119-22. PubMed ID: 8609726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnosis of multiple myeloma].
    Bartl R; Fateh-Moghadam A
    Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients.
    Sailer M; Vykoupil KF; Peest D; Coldewey R; Deicher H; Georgii A
    Eur J Haematol; 1995 Mar; 54(3):137-46. PubMed ID: 7720832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
    AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic classification and staging of multiple myeloma.
    Bartl R
    Hematol Oncol; 1988; 6(2):107-13. PubMed ID: 3391529
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation.
    Sukpanichnant S; Cousar JB; Leelasiri A; Graber SE; Greer JP; Collins RD
    Hum Pathol; 1994 Mar; 25(3):308-18. PubMed ID: 8150462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue masses in patients with multiple myeloma: a fine-needle aspiration study of 30 cases with flow cytometry and clinical correlation.
    Mukunyadzi P; Bardales RH; Wilson CS; Sawyer JR; Stanley MW
    Cancer; 2001 Aug; 93(4):257-62. PubMed ID: 11507699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.
    Bartl R; Frisch B; Burkhardt R; Jäger K; Pappenberger R; Hoffmann-Fezer G
    J Clin Pathol; 1984 Mar; 37(3):233-54. PubMed ID: 6699189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor distribution classification system for multiple myeloma: clinical features and prognosis.
    Sezaki T; Izumi K; Hoshijima T; Adachi T; Takahashi I; Kimura I
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1784-91. PubMed ID: 3564859
    [No Abstract]   [Full Text] [Related]  

  • 20. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
    Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.